02:40 GMT +316 October 2019
Listen Live
    HIV-infected H9 T cell

    HIV Drug Trial in Africa Fails As Participants Do Not Follow Prescriptions

    © Flickr/ NIAID
    Get short URL
    0 25

    The blood samples showed the majority of study participants were not taking their assigned medicines. The HIV drugs were found in less than 40 percent of samples, results of the study showed.

    MOSCOW (Sputnik) — None of the HIV drugs tested in a large clinical trial in Africa reduced the rates of HIV acquisition, partly due to the failure of the participants to properly follow the prescriptions, results of the study published in the New England Journal of Medicine on Thursday showed.

    The trial entitled VOICE for Vaginal and Oral Interventions to Control the Epidemic was carried out by the US National Institutes of Health-funded Microbicide Trials Network (MTN) from September 2009 to August 2012 in Uganda, South Africa and Zimbabwe.

    Most of the 5,029 female participants were keeping up with the clinic visits schedule and about 90 percent of participants reported that they follow the prescribed regime of taking medications.

    However, the blood samples showed the majority of study participants were not taking their assigned medicines. The HIV drugs were found in less than 40 percent of samples, results of the study showed.

    The study revealed that participants were skipping drugs mostly because of prejudices resulting from a lack of education.

    According to the journal, most women joined the trial because it guaranteed free gynecological exams every month at a professional clinic, as well as a stipend of $10 to $15 per visit.


    Smartphone Dongle Spots HIV, Syphilis in Minutes
    Russian HIV Vaccine Passes 2nd Clinical Trial Phase, Health Ministry Says
    Chinese Villagers Vote to Banish HIV-Positive Boy
    Cambodia Commits to Stopping HIV Infections by 2020: UNAIDS
    medicine, health, HIV, Uganda
    Community standardsDiscussion
    Comment via FacebookComment via Sputnik